Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 4/20 | 0.44 |
| ▸ | CNR2 | P34972 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2913398 | 0.93 | POLB (0.46) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL2913400 | 0.93 | POLB (0.46) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL6193034 | 0.91 | SMN1; SMN2 (0.42) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL15194567 | 0.91 | SMN1; SMN2 (0.45) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL24928818 | 0.91 | POLB (0.42) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL15193817 | 0.89 | SMN1; SMN2 (0.42) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL17001967 | 0.87 | FKBP1A (0.42) | POLBCNR1CNR2SMN1; SMN2FKBP1A | |
| SCHEMBL17001850 | 0.86 | FKBP1A (0.44) | POLBCNR1CNR2FKBP1AALDH1A1 | |
| SCHEMBL12881541 | 0.86 | FKBP1A (0.44) | POLBCNR1CNR2FKBP1AALDH1A1 | |
| SCHEMBL20909019 | 0.86 | FKBP1A (0.44) | POLBCNR1CNR2FKBP1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | POLB 3636/4885CNR1 4399/4885CNR2 4727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.